← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.3M

Shares

12,000

Price

$188

Filed

Jan 23

Insider

Name

Pizzie Nick

Title

Chief Financial Officer

CIK

0001742143

Roles

Officer

Transaction Details

Transaction Date

2026-01-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

42,588

Footnotes

Represents an exercise of stock options which was held for 8 years and exercised prior to the 10-year expiration date of such options. | Such transaction was pursuant to a pre-approved 10b5-1 plan. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $185.09 and $191.12. | Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan. | Represents additional shares indirectly beneficially owned by the reporting person as custodian for his children's UTMA accounts.

Filing Info

Accession No.

0001193125-26-021378

Form Type

4

Issuer CIK

0001579428

Pizzie Nick's History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2026-01-22 AXSM M $42K
2026-01-22 AXSM $2.3M
2026-01-22 AXSM M $0

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22